PG
PRAH
Pendal Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-696,307
| Closed | -$115M | – | 673 |
|
2021
Q2 | $115M | Buy |
696,307
+6,237
| +0.9% | +$1.03M | 1.05% | 32 |
|
2021
Q1 | $106M | Sell |
690,070
-339,963
| -33% | -$52.1M | 1.04% | 31 |
|
2020
Q4 | $129M | Sell |
1,030,033
-12,731
| -1% | -$1.6M | 1.35% | 17 |
|
2020
Q3 | $106M | Buy |
1,042,764
+16,295
| +2% | +$1.65M | 1.29% | 24 |
|
2020
Q2 | $99.9M | Sell |
1,026,469
-26,783
| -3% | -$2.61M | 1.36% | 18 |
|
2020
Q1 | $87.5M | Buy |
1,053,252
+89,942
| +9% | +$7.47M | 1.49% | 15 |
|
2019
Q4 | $107M | Sell |
963,310
-9,990
| -1% | -$1.11M | 1.4% | 16 |
|
2019
Q3 | $96.6M | Buy |
973,300
+74,313
| +8% | +$7.37M | 1.26% | 27 |
|
2019
Q2 | $78.2M | Buy |
898,987
+74,844
| +9% | +$6.51M | 1.09% | 29 |
|
2019
Q1 | $90.9M | Sell |
824,143
-59,358
| -7% | -$6.55M | 1.25% | 19 |
|
2018
Q4 | $70.5M | Buy |
+883,501
| New | +$70.5M | 1.13% | 31 |
|